Home › Trial NCT02154022
Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity
- Trial IDNCT02154022
- StatusEnrolling By Invitation
- PhaseN/A
- Study typeObservational
- SponsorNational Cancer Institute (NCI)
- Enrollment100
- Start date2014-07-31
- ConditionsCancer · Solid Tumors · Neoplasm
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.